Option Care Health (OPCH) EBITDA (2009 - 2026)

Option Care Health (OPCH) has 18 years of EBITDA data on file, last reported at $85.1 million in Q2 2026.

• Quarterly EBITDA rose 2.94% year-over-year to $85.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $333.7 million (changed 0.1% YoY) and the FY2025 annual result came in at $337.9 million, up 4.99% from the prior year.
• EBITDA climbed to $85.1 million in Q2 2026, from $72.5 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $91.5 million in Q4 2025 to a low of $52.2 million in Q1 2022.
• A 5-year average of $76.2 million and a median of $80.9 million in 2023 frame the typical range for EBITDA.
• Annual changes were most pronounced in 2022 — EBITDA soared 79.57% — and 2026, when it fell 8.39%.
• Tracing OPCH's EBITDA over 5 years: stood at $68.2 million in 2022, then gained by 24.0% to $84.6 million in 2023, then advanced by 2.93% to $87.0 million in 2024, then increased by 5.13% to $91.5 million in 2025, then decreased by 6.95% to $85.1 million in 2026.
• The last three EBITDA figures came in at $85.1 million (Q2 2026), $72.5 million (Q1 2026), and $91.5 million (Q4 2025), per Business Quant data.